New documentation to boost pharmacovigilance in Belgium
This article was originally published in Scrip
Executive Summary
A new form has been created for health professionals to supply information on the side-effects of medicines to the Belgian centre of pharmacovigilance for medicines for human use (CBPH), following efforts by the federal agency of medicines and health products (AFMPS).